Document is current

Article History

Received: 29 January 2025

Accepted: 16 March 2025

First Online: 29 April 2025

Declarations

:

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

: • Bartoletti Michele: fees for lectures from Gilead, Advanz, Pfizer, MSD, Biomerieux. Research grant from MSD.• Bassetti Matteo: fees for Consultant activities (Advisory Board), Speaker and research funding from Angelini, Cidara, Gilead, Menarini, MSD, Pfizer, Shionogi, Mundipharma.• Bussini Linda: none• Cortegiani Andrea: fees for lectures and/or advisory board membership from Gilead, MSD, Mundipharma, Pfizer, Shionogi.• De Pascale Gennaro: publication grant from GILEAD.• De Rosa Francesco: lectures’ fees from Gilead Sciences• Falcone Marco: unconditional grants from MSD, Gilead and speaker honoraria from Shionogi, Pfizer, Menarini, MSD, Gilead, GSK, MundiPharma and TermoFisher.• Giannella Maddalena: grants from Pfizer, MSD, Gilead and BioMerieux as a speaker; grants from MSD and Takeda as an advisory board member; research grant from Pfizer.• Girardis Massimo: fees for activity as speaker to congress and consultant to advisory board past 5 years from MSD, PFIZER, ESTOR, BIOMERIEUX, BIOTEST, FRESENIUS, GILEAD, Shionogi, VIATRIS.• Grossi Paolo: advisory board fees’ member from BIOTEST, GILEAD, TAKEDA, ASTRA-ZENECA, ALLOVIR and Speaker’s bureau fees’ member from MSD, GILEAD, BIOTEST, TAKEDA, ASTRA-ZENECA.• Mikulska Malgorzata: lecture or board meeting honoraria from Allovir, Gilead, Janssen, Moderna, Mundipharma, Pfizer and Shionogi; grant to my institution from Gilead.• Navalesi Paolo: research grants from Gilead and consultant for advisory boards for Gilead.• Pea Federico: has participated in speaker’s bureau for AdvanzPharma, Gilead, InfectoPharm, Menarini, MSD, Pfizer, Sanofi-Aventis, Shionogi, Viatris and as consultant for AdvanzPharma, Gilead, MSD, Mundipharma, Pfizer, Shionogi, Viatris• Sanguinetti Maurizio: no conflict of interest• Tascini Carlo: in the last two years I had direct financial relationships with the following companies: Menarini, MSD, Pfizer, Angelini, Gilead, Novartis, Biomerieux, Thermofisher, Zambon, Hikma, Avir Pharma, Shionogi, Biotest, Viatris• Viaggi Bruno: fees from Abbott, Accelerate Diagnostics, Ada, Advanz Pharma, Alifax, Angelini, Becton Dickinson, Bellco, Biomerieux, Biotest, Cepheid, Correvio, Diasorin, Emmegi Diagnostica, Gilead, InfectoPharm, Menarini, MSD Italia, Nordic Pharma, Pfizer, Shionogi, Thermo Fisher Scientific, Viatris• Viale Pierluigi: received payments or honoraria for lectures, presentations, speaker bureaus, advisory board attendance, manuscript writing or educational events from: Alifax, Allianz pharma, Astra Zeneca, Biomerieux, Gilead Sciences, Menarini, MSD, Mundipharma, Pfizer, Shionogi, Viatris